as on November 1, 2025 at 12:36 am IST
Day's Low
Day's High

2.14%
Downside
2.91%
Upside

52 Week's Low
52 Week's High

57.09%
Downside
103.50%
Upside

Check Protara Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$200.6M
EPS (TTM)
-1.48
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-57.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-43.02%
Compare market cap, revenue, PE, and other key metrics of Protara Therapeutics Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $200.6M | -71.35% | NA | 0.00% | |
| BUY | $41.1B | 489.62% | -16.34 | -259.82% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Protara Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protara Therapeutics Inc investment value today
Current value as on today
₹2,10,821
Returns
₹1,10,821
(+110.82%)
Returns from Protara Therapeutics Inc Stock
₹1,05,179 (+105.18%)
Dollar Returns*
₹5,642 (+5.64%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Protara Therapeutics Inc. Average target price of $25
Get share price movements and forecasts by analysts on Protara Therapeutics Inc.
What analysts predicted
79.4%UPSIDE
Target Price
$25
Current Price
$5.15
Analyzed by
11 Analysts
Target
$25.00
Protara Therapeutics Inc target price $25, a slight upside of 79.4% compared to current price of $5.15. According to 11 analysts rating.
Search interest for Protara Therapeutics Inc Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:25% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 1 month, TARA stock has moved up by 18.2%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Insmed Incorporated has given 1021.4% return, outperforming this stock by 954.0%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 83.9%
| Organisation | Protara Therapeutics Inc | 
| Headquarters | 345 Park Avenue South, New York, NY, United States, 10010 | 
| Industry | Health Technology | 
| CEO | Mr. Jesse Shefferman | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Ms. Justine O'Malley | Senior Vice President of Investor Relations & Corporate Affairs | 
| Ms. Mary J. Grendell J.D. | General Counsel & Corporate Secretary | 
| Mr. William Conkling | Chief Commercial Officer | 
| Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D. | Co-Founder & Chief Scientific Operations Officer | 
| Mr. Patrick Fabbio M.B.A. | Chief Financial Officer | 
| Ms. Hannah Fry | VP, Principal Accounting Officer & Controller | 
| Dr. Shane Williams Ph.D. | Chief People Officer | 
| Dr. Leonardo Viana Nicacio M.D. | Chief Medical Officer | 
| Mr. Jesse Shefferman | Co-founder, CEO, President & Director | 
Protara Therapeutics Inc share price today is $5.15 as on . Protara Therapeutics Inc share today touched a day high of $5.3 and a low of $5.04.
Protara Therapeutics Inc share touched a 52 week high of $10.48 on and a 52 week low of $2.21 on . Protara Therapeutics Inc stock price today i.e. is trending at $5.15,which is 50.86% down from its 52 week high and 133.03% up from its 52 week low.
Protara Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Protara Therapeutics Inc (TARA) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.65 in Protara Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Protara Therapeutics Inc share’s latest price of $5.15 as on November 1, 2025 at 12:36 am IST, you will get 1.9417 shares of Protara Therapeutics Inc. Learn more about
          
            fractional shares .
        
Protara Therapeutics Inc stock has given -71.35% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?